Evidence map›Paper›PMID 42746338›Full record

ReviewLancet regional health. Americas2026

An echocardiographic appreciation of rheumatic heart disease: phenotypic variability of valvular involvement and its prognostic implications.

Maria Carmo P Nunes, Pilly Chillo, Sheila Klassen, Dorah Nampijjad, Fernanda de Azevedo Figueiredo, Nayana Flamini Arantes Gomes, Adson Patrik Vieira Carvalho, Carolina K Soares, Estela Fofano Rodrigues, Antonio Mutarelli and 8 more

Abstract readReview
In one paragraph

Review in Lancet regional health. Americas, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Maria Carmo P NunesHospital das Clinicas, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Pilly ChilloMuhimbili University of Health and Allied Sciences, Dar es Salaam, Dar es Salaam Region, Tanzania.
Sheila KlassenDivision of Cardiovascular Medicine and Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, USA.
Dorah NampijjadFaculty of Paediatrics & Child Health Mbarara U. of Science and Technology, Mbarara, Uganda.
Fernanda de Azevedo FigueiredoInfectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Nayana Flamini Arantes GomesHospital das Clinicas, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Adson Patrik Vieira CarvalhoHospital das Clinicas, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Carolina K SoaresInfectious Diseases and Tropical Medicine, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Estela Fofano RodriguesHospital das Clinicas, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Antonio MutarelliHospital das Clinicas, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Alexandre PantaleãoHospital das Clinicas, School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Juan Manuel DíazDepartment of Microbiology and Immunology, Western University, London, Ontario, Canada.
Jacob P Dal-BiancoCardiac Ultrasound Lab, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Judy HungCardiac Ultrasound Lab, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
John K McCormickDepartment of Microbiology and Immunology, Western University, London, Ontario, Canada.
Robert A LevineCardiac Ultrasound Lab, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Leducq PRIMA Network: Preventing Rheumatic Injury Biomarker Alliancej
Leducq PRIMA Network: Preventing Rheumatic Injury Biomarker Alliance

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatic heart disease (RHD) remains a major cause of cardiovascular morbidity and premature mortality in low- and middle-income countries. This review examines RHD from an echocardiographic perspective, emphasizing how valve-specific phenotypes, hemodynamic burden, and disease progression shape clinical presentation, prognosis, and management. The evolution of echocardiography, from M-mode and two-dimensional imaging to Doppler, strain, and three-dimensional techniques, has transformed understanding of rheumatic valve disease and established imaging as central to diagnosis, risk stratification, and therapeutic guidance. Rheumatic mitral stenosis, in particular, served as a model for the development of key echocardiographic principles in valve morphology, hemodynamics, and intervention planning. Beyond anatomical severity, physiological variables such as exercise-induced pulmonary pressure changes and net atrioventricular compliance provide important prognostic information and better reflect functional impairment. Across the spectrum of disease, echocardiography remains fundamental for early detection, phenotypic characterization, longitudinal surveillance, and individualized management of RHD.

Indexed as

EchocardiogramMitral stenosisMitral valve diseaseRheumatic heart disease

Identifiers

PMID42746338
PMCPMC13575803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.